The mean of analysts' price targets for Septerna, Inc. (SEPN) points to a 151.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among ...

We have highlighted five single-stock ETFs that have doubled over the past month amid a historic Wall Street comeback.

About a fourth of younger men surveyed in the United States feel lonely, which is significantly higher than the national ...

FDA officials have warned the American public to not eat, sell or serve cucumbers grown and distributed by two Florida ...

As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)’s competing ...

Novo Nordisk is teaming up with Septerna to develop new pills to treat obesity, type 2 diabetes, and other metabolic diseases.

The story of chronic itch and its impact on quality of life is one dermatologists have heard often. Until recently, treatment ...